arrow
A

Anthony Maxwell

University of Manchester
H指数:38
被引数:4,395

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates

钼靶检查与病理学检查对筛查发现的DCIS大小评估的差异:风险因素及其对同侧复发率的影响

2025-09-030
PRE
Randomised phase-2 screening trial of intermittent energy restriction plus resistance exercise versus resistance exercise alone during chemotherapy for advanced breast cancer

针对晚期乳腺癌化疗期间间歇性能量限制联合抗阻运动与单纯抗阻运动的随机化二期筛查试验

2025-07-310
OAAI
The IBRAnet localisation study; a UK National multi-centre cohort study comparing the safety and effectiveness of guidewire, RFID, and magnetic seed- guided localisation for impalpable breast lesions
2024-05-020
PRE
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420) (Mar 2023, 10.1038/s41416-023-02250-w )
2023-04-240
OAAI
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)

量化风险分层乳腺癌筛查作为常规实践与常规筛查实时交付时的效果: bc-predict非随机对照研究 (NCT04359420)

2023-04-015
OA
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)-results from the UK Sloane Project
2022-10-1213
OA
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel

筛查年龄女性的乳腺癌风险分层: 增加乳腺摄影密度,多基因风险和基因面板的增量效应

2022-07-0132
OA
A longitudinal cohort study of outcomes in 311 women with unresected ductal carcinoma in situ detected through the English breast screening programme
2022-02-150
PRE
The diagnosis and prognosis of ductal carcinoma in situ (DCIS) with microinvasion - Results from the United Kingdom Sloane project
2022-02-150
PRE
Results from the breast cancer - anti progestin prevention study 1 (BC-APPS1) trial - a novel approach in breast cancer prevention
2022-02-150
PRE